Mexaratio (Paracetamol)

Paracetamol works by inhibiting cyclooxygenase enzymes in the central nervous system, which reduces the production of prostaglandins that signal pain and regulate body temperature. This central action provides pain relief and fever reduction while having minimal peripheral anti‑inflammatory effect.

The appropriate dose of Mexaratio is determined by a qualified prescriber based on the patient’s age, weight, clinical condition, and local guidelines. Adults typically receive a standard adult dose, while pediatric dosing follows weight‑based recommendations, but exact amounts should always be confirmed by a healthcare professional.

Safety data for paracetamol in pregnancy and lactation are limited for this specific product. Healthcare providers generally weigh potential benefits against risks. Women who are pregnant or breastfeeding should consult their physician before using Mexaratio to ensure it is appropriate for their situation.

To order Mexaratio, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Both Mexaratio (paracetamol) and ibuprofen relieve pain and fever, but they belong to different classes. Paracetamol has minimal anti‑inflammatory activity and a lower risk of gastrointestinal irritation, while ibuprofen provides stronger anti‑inflammatory effects but may affect stomach lining and kidney function. Choice depends on the clinical need and patient tolerance.

Mexaratio should be stored at temperatures below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Mexaratio is administered orally. The tablet should be swallowed whole with a glass of water. It can be taken with or without food, but patients should follow the dosing instructions provided by their healthcare professional.

The most serious risks include severe liver injury (hepatotoxicity), especially with overdose or chronic high‑dose use, and rare severe skin reactions such as Stevens‑Johnson syndrome. Prompt medical attention is required if signs of liver dysfunction or serious skin changes occur.

Individuals with known hypersensitivity to paracetamol or any excipients in the tablet should avoid Mexaratio. Patients with severe liver disease, those who consume excessive alcohol, and children under the age recommended by local guidelines should not use this product without medical supervision.